Insurance Denials and Diabetes: A Growing Crisis

More than 37 million Americans live with diabetes, and for each of them, reliable access to insulin, glucose monitors, insulin pumps, continuous glucose monitors (CGMs), and routine medical care is not optional—it is essential. When insurance companies deny coverage for these treatments, the consequences can be severe: diabetic ketoacidosis, life-threatening hypoglycemic episodes, and progressive damage to the kidneys, eyes, and nerves. Unfortunately, denials remain a daily reality for countless patients, often for treatments that physicians have explicitly prescribed. The good news is that a powerful network of federal and state laws exists to protect diabetics from unfair insurance practices. Understanding these legal protections is the first step toward securing the continuous, life-sustaining care you deserve.

Federal Laws That Shield Diabetics from Unfair Denials

Several major federal statutes create legal safeguards against discrimination and unreasonable coverage denials. Each law operates differently, and knowing how they intersect can help you mount a more effective challenge.

Americans with Disabilities Act (ADA) and the ADA Amendments Act

The ADA prohibits discrimination against individuals with disabilities in employment, public services, and public accommodations. Diabetes meets the ADA’s definition of a disability because it substantially limits major life activities such as eating, caring for oneself, and endocrine function. Under Title I of the ADA, employers with 15 or more employees must provide reasonable accommodations—for example, breaks to check blood sugar, a private space to take insulin, or a flexible schedule for medical appointments. While the ADA does not directly regulate insurance benefits, it influences how courts view discrimination when an employer or a health plan denies coverage for diabetes care. Courts have held that blanket exclusions for diabetes treatments—such as denying coverage for insulin pumps while covering other durable medical equipment—may violate the ADA if they result in disparate treatment of people with disabilities. This means that if an insurer's policies systematically disadvantage diabetics compared to others with similar medical needs, a discrimination claim may be viable.

Affordable Care Act (ACA)

The ACA provides some of the most powerful protections for diabetics. Since 2014, insurance companies cannot deny coverage or charge higher premiums based on pre-existing conditions, including diabetes. This protection applies to all individual and small-group market plans. Additionally, the ACA requires non-grandfathered plans to cover ten categories of Essential Health Benefits (EHBs). Two EHBs directly affect diabetics:

  • Prescription drugs – Plans must cover at least one drug per category in each therapeutic class. For diabetes, this includes insulin formulations, oral hypoglycemics, and GLP-1 receptor agonists. However, insurers may still use step therapy or prior authorization, which patients can challenge through the appeals process.
  • Preventive and wellness services – All non-grandfathered plans must cover certain preventive services at no cost-sharing, including blood glucose testing for adults with hypertension or who are at risk for diabetes, and diabetes screening for those with a family history. The list also includes diet counseling and obesity screening.

Importantly, the ACA also eliminated annual and lifetime dollar limits on essential health benefits, a critical protection for diabetics who require expensive supplies year after year. Without this provision, a single hospital stay for diabetic ketoacidosis could exhaust a lifetime cap, leaving patients without coverage for ongoing care.

Health Insurance Portability and Accountability Act (HIPAA)

HIPAA is best known for protecting health information privacy, but its portability provisions also help diabetics when changing jobs or plans. For group health plans, HIPAA limits the time a new plan can impose a pre-existing condition exclusion period to 12 months (reduced by creditable continuous coverage). Although the ACA supersedes HIPAA for most Americans by banning pre-existing exclusions outright, HIPAA remains relevant for certain self-insured plans that may still have limited exclusions. Patients switching from one job-based plan to another should understand their HIPAA rights to avoid gaps in insulin or supplies. For example, if you change employers mid-year, HIPAA ensures that your new plan cannot impose a waiting period for diabetes coverage if you had continuous creditable coverage under your previous plan.

Employee Retirement Income Security Act (ERISA)

Most employer-sponsored health insurance plans are governed by ERISA, a federal law that sets standards for benefit plans. ERISA grants participants the right to sue for benefits and requires plans to provide a fair appeals process. If a diabetic’s claim for a CGM or insulin pump is denied, ERISA mandates that the plan give a full explanation and allow an internal appeal. If that appeal fails, the patient can file a lawsuit in federal court to recover the denied benefits plus attorney’s fees. ERISA lawsuits are often complex, but they can be powerful tools when an insurer arbitrarily denies coverage for medically necessary diabetes technology. One key advantage of ERISA claims is that the court reviews the administrative record, meaning the evidence you submit during the appeals process becomes the foundation of your case. This makes it essential to build a thorough record from the start.

State-Level Protections: Going Beyond Federal Law

Many states have enacted laws that go beyond federal protections, creating additional layers of security for diabetics. More than 20 states have insulin copay caps, limiting out-of-pocket costs to $25–50 per month. Several states also mandate coverage for diabetes self-management training, CGMs, and insulin pumps. State laws may also require parity between diabetes supplies and other durable medical equipment. Patients should check their state insurance department’s website for specific mandates. In some states, external review can overturn denials even when the insurer’s own internal appeal is exhausted. For example, California, New York, and Texas have robust external review processes that give patients an independent second opinion on medical necessity decisions. If you live in a state with strong consumer protections, you may have additional leverage when challenging a denial.

Common Reasons for Insurance Denials and How to Overcome Them

Insurance denial letters often cite one of several standard rationales. Knowing the right response for each can dramatically improve the chances of reversal.

Step Therapy (Fail-First Protocols)

Insurers may require a diabetic to try and fail a less expensive drug—such as metformin or a specific insulin formulation—before covering the prescribed one. Although step therapy can reduce costs, it can be dangerous for patients with unstable glucose control. To challenge this, obtain a written letter from your endocrinologist explaining why the step therapy is medically contraindicated. Common reasons include a history of severe hypoglycemia on the alternative drug, documented allergic reactions, or rapid disease progression that makes a trial unsafe. Most plans allow an expedited exception review for urgent situations, which means your doctor can submit the request and expect a response within 72 hours. If the denial persists, escalate to the state insurance department or request an external review.

Prior Authorization Delays or Denials

Many CGMs and insulin pumps require prior approval. Denials often cite "lack of medical necessity." The best counter is a comprehensive letter of medical necessity that includes:

  • Patient’s HbA1c trends over the past 12–24 months, showing persistent elevation or variability despite standard therapy.
  • Frequency of hypoglycemic events, including any emergency room visits or hospitalizations.
  • Documented complications such as neuropathy, retinopathy, or nephropathy that justify more advanced monitoring or therapy.
  • Peer-reviewed literature showing improved outcomes with the requested device compared to standard care.
  • Records of prior treatments and the specific reasons they failed—such as adverse reactions or lack of efficacy.

Alternatively, ask the insurance company for the specific clinical criteria they used to deny the claim. If their own internal guidelines support the device, use that as leverage. Many denials are overturned simply because the reviewer did not have all the relevant information.

Formulary Exclusions

Insurers may exclude a specific insulin analog or oral medication from their drug list. While the ACA requires at least one drug per class, the plan may not cover your doctor’s preferred brand. If your doctor believes the excluded drug is medically necessary—for example, due to a documented allergic reaction to the covered alternative, or absorption issues that make the preferred formulation ineffective—request a formulary exception. The plan must respond within 72 hours for expedited cases (urgent need) or 30 days for non-urgent. If the exception is denied, ask your doctor to provide additional clinical evidence, such as published studies showing superior outcomes with the excluded drug in patients similar to you.

Out-of-Network Denials for Specialists

Endocrinologists or diabetes educators may be out of network. If the closest in-network provider lacks expertise in diabetes management, or the wait time for an appointment is unreasonably long—for instance, more than 60 days—some states allow "standing referrals" for patients with chronic conditions. File an appeal citing the network inadequacy and request an out-of-network benefit at in-network cost-sharing. Include documentation from your primary care physician explaining why an out-of-network specialist is necessary for your care. If the insurer denies the appeal, contact your state insurance department to determine whether your state has a network adequacy standard that the plan is violating.

A Step-by-Step Guide to Challenging an Insurance Denial

When a denial arrives, do not panic. A systematic approach can often reverse the decision. Follow these steps:

  1. Read the denial letter thoroughly – Note the specific reason (medical necessity, step therapy, missing information) and the deadline to appeal (usually 60 to 180 days). Mark the deadline on your calendar and do not miss it.
  2. Gather supporting medical records – Ask your doctor for a detailed letter linking the denied treatment to improved outcomes and demonstrating failure of alternatives. Include lab results, clinic notes, and any relevant imaging or test results.
  3. File an internal appeal – Submit the letter and records via the plan’s appeals process. Use certified mail or the online portal to get proof of receipt. Keep copies of everything you send.
  4. Request an expedited review – If waiting 30 days would harm your health—for example, if you are at risk of diabetic ketoacidosis or severe hypoglycemia—call the plan and request an expedited decision. The plan must respond within 72 hours under federal law.
  5. After a denied internal appeal – Many states and federal plans provide the right to an external independent review. This is a binding review by a third party who is not affiliated with the insurer. Ask your state insurance department or the U.S. Department of Health and Human Services (HHS) for guidance. External reviews overturn denials roughly 40–60% of the time, making this one of the most effective tools available.
  6. File a complaint – Contact your state’s insurance commissioner or the U.S. Department of Labor (for ERISA plans). They can investigate systemic issues and may compel the insurer to change its practices.
  7. Consult an attorney – If the claim involves substantial financial harm—such as the lifetime cost of an insulin pump or ongoing CGM supplies—or clear discrimination, a health law or ERISA attorney can file a lawsuit. Many attorneys offer free initial consultations and work on a contingency fee basis.

When administrative appeals fail, litigation becomes a viable option. Common legal claims include:

  • ERISA benefits claims – Suing to recover denied benefits plus penalties for unreasonable delays. Courts give some deference to plan administrators, but egregious errors—such as ignoring clear medical evidence or applying the wrong clinical criteria—can be reversed. Successful plaintiffs may also recover attorney’s fees and court costs.
  • ADA claims – Suing an insurer or employer for discrimination if the denial resulted from a categorical exclusion that treats diabetics worse than other people with disabilities. For example, if an employer’s health plan covers CGMs for employees with cardiac conditions but excludes them for diabetics, that may constitute unlawful discrimination.
  • State law breach of contract – If the plan’s language explicitly covers the treatment—for instance, the policy says "insulin infusion pumps are covered"—and the insurer arbitrarily denies it, a breach of contract claim may succeed. State law remedies can include actual damages, consequential damages, and in some cases, punitive damages for bad faith.

Class-action lawsuits have succeeded against insurers for systematically denying CGM coverage to Type 2 diabetics or for refusing to cover temperature-stable insulins. Patients considering litigation should keep detailed records of all communications, denial letters, and medical records. A well-documented case is far more likely to succeed, whether in settlement or at trial.

Resources and Advocacy Organizations That Can Help

No diabetic should navigate insurance denials alone. The following organizations offer free guidance, sample appeal letters, and legal referrals:

  • American Diabetes Association (ADA) – Provides a Health Insurance Help Center with state-by-state information, model appeal letters, and a legal advocacy program. The ADA also offers a toll-free help line staffed by trained advocates.
  • Diabetes Patient Advocacy Coalition (DPAC) – Offers one-on-one support for denials and coordinates legal action. DPAC has a network of pro bono attorneys who specialize in diabetes-related insurance cases.
  • JDRF – Focused on Type 1 diabetes, but also covers technology access and insurance issues. JDRF has a dedicated advocacy team that works on state and federal policy changes.
  • National Disability Rights Network (NDRN) – Provides legal assistance to people with disabilities facing discrimination, including healthcare denials. Each state has a Protection and Advocacy agency that is part of this network.
  • State Health Insurance Assistance Programs (SHIPs) – Free, federally funded counselors who help consumers understand their rights and appeal denials. Find your local SHIP at shiphelp.org. SHIP counselors are trained to navigate Medicare, Medicaid, and private insurance appeals.
  • Legal Aid Organizations – Many local legal aid offices handle healthcare access cases. Use LSC.gov to find a provider near you. Legal aid is income-based and often free for qualifying individuals.

Conclusion: Your Rights Are Stronger Than You Think

Diabetes management is demanding enough without the added stress of battling an insurance company for coverage. But knowledge of legal protections—from the ADA and ACA to state-specific laws—can turn the tables. By understanding your rights, gathering strong medical evidence, and using every available appeal pathway, you can fight denials effectively. Whether it is a copay cap for insulin, a step therapy override, or a lawsuit under ERISA, the law is on your side when you know how to use it. Stay persistent, get help from advocacy groups, and never assume a denial is final. Your health depends on it.